SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,054 | -50.5% | 13,272 | -33.7% | 0.00% | – |
| Q2 2023 | $93,037 | +0.5% | 20,008 | -0.2% | 0.00% | – |
| Q1 2023 | $92,599 | -46.7% | 20,043 | -6.9% | 0.00% | – |
| Q4 2022 | $173,890 | +62.5% | 21,521 | +11.4% | 0.00% | – |
| Q3 2022 | $107,000 | +9.2% | 19,311 | +2.6% | 0.00% | – |
| Q2 2022 | $98,000 | -74.1% | 18,823 | -59.1% | 0.00% | – |
| Q1 2022 | $379,000 | -49.9% | 46,071 | -9.4% | 0.00% | -100.0% |
| Q4 2021 | $757,000 | -19.6% | 50,877 | +2.2% | 0.00% | 0.0% |
| Q3 2021 | $941,000 | -15.4% | 49,799 | -16.7% | 0.00% | 0.0% |
| Q2 2021 | $1,112,000 | -0.4% | 59,794 | +22.0% | 0.00% | 0.0% |
| Q1 2021 | $1,116,000 | +21.8% | 49,024 | +16.2% | 0.00% | 0.0% |
| Q4 2020 | $916,000 | +132.5% | 42,177 | +7.5% | 0.00% | 0.0% |
| Q3 2020 | $394,000 | +101.0% | 39,223 | +55.0% | 0.00% | – |
| Q2 2020 | $196,000 | +13.3% | 25,298 | +49.3% | 0.00% | – |
| Q1 2020 | $173,000 | -6.0% | 16,946 | +1.2% | 0.00% | – |
| Q4 2019 | $184,000 | +21.1% | 16,752 | 0.0% | 0.00% | – |
| Q3 2019 | $152,000 | -20.4% | 16,752 | 0.0% | 0.00% | – |
| Q2 2019 | $191,000 | +67.5% | 16,752 | +67.4% | 0.00% | – |
| Q1 2019 | $114,000 | +9.6% | 10,005 | -13.5% | 0.00% | – |
| Q4 2018 | $104,000 | – | 11,573 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |